Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors.

Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors.

A Sendai virus (SeV) vector is being developed for delivery of an HIV immunogen. SeV is not known to cause disease in humans. Because it is genetically and antigenically related to human parainfluenza virus type 1 (hPIV-1), it is important to determine whether pre-existing hPIV-1 antibodies will aff...

Full description

Bibliographic Details
Main Authors: Hara, H, Hironaka, T, Inoue, M, Iida, A, Shu, T, Hasegawa, M, Nagai, Y, Falsey, A, Kamali, A, Anzala, O, Sanders, E, Karita, E, Mwananyanda, L, Vasan, S, Lombardo, A, Parks, C, Sayeed, E, Krebs, M, Cormier, E, Ackland, J, Price, M, Excler, J
Format: Journal article
Language:English
Published: 2011

Similar Items